Tag Archives: Stem Cell Research

Round-up of stories on adult stem cell research and abortion

As you know, Obama is making scientific progress and patient care take a back-seat to feminist ideology. He appeases his pro-abortion special interest groups by wasting money on unproven embryonic stem cell research, while neglecting proven therapies based on adult stem cell research. Who cares about patient liberty and curing diseases?

Let’s take a look and see what adult stem cells can do.

UPI reports that adult stem cells can revert to an embryonic state.

U.S. scientists say they have, for the first time, returned adult mouse cells to their embryonic pluripotent state, meaning they can become any cell type.

The University of California-San Francisco researchers said they used tiny molecules called microRNAs to reprogram the cells.

The achievement suggests scientists will soon be able to replace retroviruses and even genes currently used in laboratory experiments to induce pluripotency in adult cells. The researchers said that would make potential stem cell-based therapies safer by eliminating risks posed to humans by these DNA-based methods, including alteration of the genome and risk of cancer.

Adult stem cells provide solutions for stroke victims.

The good news continues to flow about the first stroke patient successfully treated in Houston using the patient’s own adult stem cells. The patient, Roland Henrich, was originally admitted to the emergency room at Memorial Hermann-Texas Medical Center on March 25, 2009 with signs of stroke–he could not speak and had significant weakness on his right side. Because it was beyond the few hours window for use of the clot-dissolving drug TPA, the adult stem cell trial was his only option. The next day some of his bone marrow was removed, the adult stem cells separated, and returned intravenously to the patient. In less than a week doctors noted that he was recovering remarkably well and had not shown any signs of paralysis. Within 11 days of the treatment Mr. Henrich was walking, climbing stairs unassisted, and said his first word after the stroke, captured on a local news video and surprising his own doctor and leader of the clinical trial, Dr. Sean Savitz. His wife says now he has spoken several single words and phrases and has fed the cows by himself.

Adult stem cells provide solutions for infertile women.

Chinese scientists have published a study in Nature Cell Biology that suggests even older females retain adult stem cells that can stimulate fertility, including the production of more eggs. The evidence is in contrast to the usual dogma that women have a finite number of immature eggs, some of which mature and are ovulated, and that the number of eggs becomes depleted with age. Tilly et al. recently reviewed the evidence for and against production of new eggs after birth. Tilly’s group was one of those recently to challenge the dogma with evidence that new egg production could occur in mammals.

What the Chinese group showed is that ovaries contain stem cells that can produce more eggs, similar to the stem cells in testes that produce sperm.

Adult stem cells provide solutions for healing bones.

Patients confined to wheelchairs have been able to walk or live independently again because their broken bones finally healed, thanks to a drug that stimulates their adult stem cells. Preliminary results presented at the Orthopaedic Research Society meeting found 93% of those with an unhealed bone fracture had significant healing and pain control after treatment for only 8 to 12 weeks. Half of the 145 patients studied had non-healing fractures for 6 months or longer. The drug, teriparatide (Forteo), was approved by the FDA in 2002 for treatment of osteoporosis. A team led by Dr. J. Edward Puzas at the University of Rochester Medical Center discovered that this drug can also boost the body’s bone adult stem cell production to the point that adults’ bones appear to heal at a rate typically seen for young kids.

Adult stem cells provide solutions for diabetes.

Another success for adult stem cells, again treating Type I (juvenile) diabetes patients. As reported in a study published today in the Journal of the American Medical Association, 20 of 23 patients became insulin-independent after treatment with their own bone marrow adult stem cells. This report is a follow-up to the previous report by Voltarelli & Burt in 2007, and includes new patients as well as a longer period to follow the patients. Some of the patients have gone for four years insulin-free. The authors note in the paper that this adult stem cell treatment “remains the only treatment capable of reversing type 1 diabetes in humans.”

Adult stem cells provide solutions for treating ligaments and tendons

Recent news from London that adult stem cells will be used to repair damaged tendons and ligaments in patients. This isn’t really a new technique, but the interesting thing is that the technique is now used routinely in horses and other animals. Finally, the realization has hit that this adult stem cell treatment might work for people, too. More than 1,500 race horses have been treated using the same process, and follow-up data suggest a 50 percent reduction in re-injury over a three year period, compared with conventional treatment.

We don’t need to kill innocent unborn humans in order to make medical progress. We don’t need an excess of 32 million males due to anti-female sex-selection abortions. And we don’t need to subsidize Planned Parenthood with 350 million dollars when they already have net assets of 1 billion dollars.

And lastly, some good news. In contrast to the Democrats anti-life stance, Republicans in the Oklahoma legislature voted to ban embryonic stem cell research. Now that’s progress.

Michele Bachmann opposes Obama’s plan to fund ESCR

Representative Michele Bachmann
Representative Michele Bachmann

UPDATE: For all the people that are searching for Michele Bachmann, this blog is FILLED with stories on Michele Bachmann!!!  Here is a good summary of some of her best material. Here’s her latest video.

More recent posts

Here are my recent posts on Michele Bachmann:

Michele Bachmann on ESCR

Michele Bachmann is my favorite member of the House, and I’ve blogged about her before, here, here and here. Today, she shows that she is aware of the recent breakthroughs in stem cell research in her speech on the floor of the House. Do not miss this great video of the most conservative and articulate legislator in the House.

More videos of Michele Bachmann are here.

(H/T: The Maritime Sentry)

UPDATE: One of my other congressional favorites Mary Fallin had these comments on the ESCR intitiative:

Every human being, no matter how small or how early in his or her development, has a right to life. By allowing federal dollars to fund the destruction of human embryos, the Obama Administration is not only denying this essential truth, it is ordering taxpayers to foot the bill for research that many, including myself, find morally repugnant.

I enthusiastically support adult and cord blood stem cell research, methods which show great promise and do not involve the destruction of human life. It is a tragedy the new administration has further weakened protections of the unborn and ignored the science behind morally acceptable alternatives to embryonic stem cell research.”

Notice how she echoes the SLED-test argument, and she understands the difference between ESCR and ASCR. That’s what I like to see!

UPDATE 2: Michele Bachmann has an even better speech on the dangers of tinkering in the free market here! This one is a must see!

Major breakthrough in adult stem-cell research

There are two kinds of stem-cell research. The first kind is called embryonic stem-cell research (ESCR). This kind is opposed by pro-lifers because it kills unborn persons by extracting their stem cells for use in medical research. The second kind is called adult stem-cell research (ASCR). This kind is supported by pro-lifers.

You may be surprised to know that ESCR doesn’t work as nearly as well as ASCR. Despite all the advocacy from left-wing Hollywood actors, ESCR has not helped a single patient. But ASCR in being used for 73 different kinds of therapies. According to the Family Research Council:

…adult stem cell research had an impressive track record as of 2006-over 1100 FDA approved clinical trials in the United States for 72 different illnesses and disabilities. 2007 has seen further advances in adult stem cell research and therapy. Currently, peer-reviewed studies have documented 73 different conditions in humans where patient health has been improved through adult stem cell therapy, and over 1400 FDA approved trials are ongoing.

Adult stem cells are found throughout the human body from birth onward, in placentas, and in umbilical cord blood. Unlike embryonic stem cell research, no embryos are destroyed in retrieving them.

…There have been no successful treatment trials in human beings using embryonic stem cells.

But there were still a couple of problems with ASCR as Telic Thoughts explains here:

In 2007 scientists found a way to induce pluripotency in adult somatic cells. There were just two problems. First, it was a slow process. Second, the cells were modified via a virus delivery system which increased the risk of cancerous mutation in the future.

Cancerous mutation? That sounds bad. But wait:

Yesterday the second problem was solved as it was announced that scientists had found a way to induce pluripotency similar to that of embryonic stem cells without the use of viral delivery systems.

And their post closes with this:

Last week the Obama administration promised to move soon to repeal the funding ban on embryonic stem cell research. It will be interesting to see if this monumental scientific breakthrough will alter Obama’s course of action.

That won’t happen. For more information about why pro-lifers oppose ESCR and support ASCR, here is a series of 3 Townhall.com articles written by Greg Koukl, (first, second, third). Greg is the founder of Stand to Reason, an apologetics ministry with a heavy emphasis on bioethics.

UPDATE: Video of Michele Bachmann opposing ESCR funding.